Thus, interest has increased in the design of different scaffolds that could have effects on AD targets, such as beta secretase (BACE1), AChE, and anti-Aβ aggregation, as well as on the oxidative stress produced during AD. This evidence concerns the gene BACE1 and Alzheimer disease.